RDIF, Viscoran Ilac Agree to Produce Sputnik Vaccine in Turkey

Bloomberg, 26.04.2021

(Bloomberg) -- Viscoran Ilac has carried out necessary studies for localization of the product and aims to launch the production in the upcoming months at several facilities, Russian Direct Investment Fund says in emailed statement.

Viscoran Ilaç provides assistance in establishing partnerships with other leading local pharmaceutical producers

Technology transfer is currently being finalized with CinnaGen Ilac, while negotiations with two other production facilities are in process in order to increase the overall capacity.